GLAXOSMITHKLINE PHARMACEUTICAL (GLAXO)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 738.02 953.38 804.98 910.87 811.00 1,000.05 946.36 966.08 804.83 973.63 1,022.59 989.15
YOY Revenue Growth % 1.17% 5.27% 0.73% 16.46% 9.89% 4.9% 17.56% 6.06% -0.76% -2.64% 8.06% 2.39%
Other Income 36.80 28.47 28.34 29.87 35.85 32.19 35.06 39.46 43.76 31.27 31.82 35.71
Total Income 774.82 981.85 833.32 940.74 846.85 1,032.24 981.42 1,005.54 848.59 1,004.90 1,054.41 1,024.86
Total Expenses + 466.95 396.47 361.02 498.72 422.10 441.74 396.67 650.64 570.02 656.89 676.52 655.74
Cost of Materials Consumed 145.47 79.71 87.52 192.29 133.33 137.25 91.93 108.35 121.43 107.07 70.10 101.47
Employee Benefit Expense 165.00 145.21 141.35 172.83 151.28 150.71 124.74 152.97 152.57 138.05 151.88 164.75
Other Expenses 156.48 171.55 132.15 133.60 137.49 153.78 180.00 136.03 113.54 150.36 154.05 140.79
Operating Profit 271.07 556.91 443.96 412.15 388.90 558.31 549.69 315.44 234.81 316.74 346.07 333.41
OPM % 36.7% 58.4% 55.2% 45.2% 48% 55.8% 58.1% 32.7% 29.2% 32.5% 33.8% 33.7%
Profit Before Tax + 178.71 296.51 65.11 268.71 248.49 338.70 306.35 354.90 278.57 350.65 377.89 369.12
Tax Expense 48.13 80.97 19.62 75.63 66.84 90.01 77.77 94.76 73.87 95.65 100.71 94.18
Tax % 26.9% 27.3% 30.1% 28.1% 26.9% 26.6% 25.4% 26.7% 26.5% 27.3% 26.7% 25.5%
Profit After Tax 130.58 215.54 45.49 193.08 181.65 248.69 228.58 260.14 204.70 255.00 277.18 274.94
EPS (Basic) 6.94 12.72 9.88 11.39 10.72 14.45 13.49 15.35 12.08 14.92 16.36 16.23

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Revenue from Operations 3,723.49 3,407.25 3,216.34 3,217.51 3,193.73 3,224.68 3,128.53
YOY Revenue Growth % 9.28% 5.94% -0.04% 0.74% -0.96% 3.07% -
Other Income 142.56 123.48 101.52 76.22 110.19 77.56 101.48
Total Income 3,866.05 3,530.73 3,317.86 3,293.73 3,303.92 3,302.24 3,230.01
Total Expenses + 2,622.30 1,723.16 1,561.25 1,718.41 1,646.20 1,732.74 1,850.59
Cost of Materials Consumed 470.86 504.99 394.35 552.47 452.64 474.38 682.07
Employee Benefit Expense 579.70 624.39 594.99 610.23 614.69 628.55 537.20
Other Expenses 607.30 593.78 571.91 555.71 578.87 629.81 631.32
Operating Profit 1,101.19 1,684.09 1,655.09 1,499.10 1,547.53 1,491.94 1,277.94
OPM % 29.6% 49.4% 51.5% 46.6% 48.5% 46.3% 40.8%
Profit Before Exceptional 1,243.75 952.65 833.35 761.87 722.33 646.99 658.82
Exceptional Items 4.69 -143.61 -0.97 11.58 -172.60 -324.49 4.89
Profit Before Tax + 1,248.44 809.04 832.38 773.45 549.73 322.50 663.71
Tax Expense 329.38 224.35 224.63 -917.08 192.17 212.45 238.35
Tax % 26.4% 27.7% 27% -118.6% 35% 65.9% 35.9%
Profit After Tax 919.06 584.69 607.75 1,690.53 357.56 110.05 425.36
EPS (Basic) 54.01 34.51 35.88 99.79 21.11 6.50 25.11

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
ASSETS
Non-Current Assets + 524.57 573.49 652.51 0.00 0.00 0.00 0.00
Property, Plant & Equipment 269.54 296.80 294.81 0.00 0.00 0.00 0.00
Capital Work in Progress 14.32 13.93 20.31 0.00 0.00 0.00 0.00
Non-Current Investments 24.49 24.49 24.49 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 13.33 23.55 34.09 0.00 0.00 0.00 0.00
Current Assets + 3,576.36 2,974.31 2,675.19 0.00 0.00 0.00 0.00
Inventories 463.17 514.30 437.70 0.00 0.00 0.00 0.00
Trade Receivables 292.55 222.06 192.38 0.00 0.00 0.00 0.00
Cash and Cash Equivalents 536.22 62.15 29.74 0.00 0.00 0.00 0.00
Current Investments 1,000.00 813.22 518.29 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 169.41 169.41 169.41 0.00 0.00 0.00 0.00
Other Equity 1,779.82 1,614.68 1,583.59 0.00 0.00 0.00 0.00
Non-Current Liabilities 250.89 252.76 257.68 0.00 0.00 0.00 0.00
Current Liabilities 1,900.81 1,510.95 1,317.02 0.00 0.00 0.00 0.00
Total Liabilities 2,151.70 1,763.71 1,574.70 0.00 0.00 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Cash from Operating Activities 1,280.03 578.93 487.94 819.80 0.00 0.00 0.00
Cash from Investing Activities -36.54 14.97 805.19 -419.66 0.00 0.00 0.00
Cash from Financing Activities -769.42 -561.49 -1,544.18 -524.25 0.00 0.00 0.00
Net Increase/Decrease in Cash 474.07 32.41 -251.05 -124.11 0.00 0.00 0.00